MX9102243A - Composicion farmaceutica oral que contiene ciclosporina y un proceso para prepararse - Google Patents

Composicion farmaceutica oral que contiene ciclosporina y un proceso para prepararse

Info

Publication number
MX9102243A
MX9102243A MX9102243A MX9102243A MX9102243A MX 9102243 A MX9102243 A MX 9102243A MX 9102243 A MX9102243 A MX 9102243A MX 9102243 A MX9102243 A MX 9102243A MX 9102243 A MX9102243 A MX 9102243A
Authority
MX
Mexico
Prior art keywords
cyclosporin
pharmaceutical composition
parts
prepare
composition containing
Prior art date
Application number
MX9102243A
Other languages
English (en)
Inventor
Erno Orban
Eva Tomori-Nee-Joszt
Maria Kurthy
Tibor Balogh
Laszlo Jaszlits
Imre Moravcsik
Istvan Kovacs
Martha Jusztin-Nee-Darbai
Sandor Jancso
Erzsebet Takacs
Ilona Kiss-Nee-Loos
Katalin Kovacs-Nee-Hadady
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of MX9102243A publication Critical patent/MX9102243A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX9102243A 1990-11-27 1991-11-27 Composicion farmaceutica oral que contiene ciclosporina y un proceso para prepararse MX9102243A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU907653A HU208491B (en) 1990-11-27 1990-11-27 Process for producing oral pharmaceutical composition containing cyclosporin

Publications (1)

Publication Number Publication Date
MX9102243A true MX9102243A (es) 1992-07-08

Family

ID=10972318

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102243A MX9102243A (es) 1990-11-27 1991-11-27 Composicion farmaceutica oral que contiene ciclosporina y un proceso para prepararse

Country Status (18)

Country Link
US (1) US5430017A (es)
EP (1) EP0512109B1 (es)
JP (1) JPH082795B2 (es)
AT (1) ATE129898T1 (es)
AU (1) AU651154B2 (es)
CA (1) CA2072983A1 (es)
CS (1) CS230492A3 (es)
DE (1) DE69114476T2 (es)
DK (1) DK0512109T3 (es)
FI (1) FI923385A0 (es)
HU (1) HU208491B (es)
IL (1) IL100162A (es)
MX (1) MX9102243A (es)
NO (1) NO922961L (es)
NZ (1) NZ240762A (es)
PT (1) PT99623A (es)
WO (1) WO1992009299A1 (es)
ZA (1) ZA919352B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
DK0789580T3 (da) 1994-11-03 2002-09-09 Novartis Ag Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
EP0789561B1 (en) * 1995-08-25 2004-04-07 Sangstat Medical Corporation Oral cyclosporin formulations
AU764599B2 (en) * 1995-08-25 2003-08-21 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
EP0988046B1 (en) 1997-01-30 2004-09-15 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin a
CA2284000C (en) * 1997-03-12 2012-01-03 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
DE69939335D1 (de) 1998-12-30 2008-09-25 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE290460C (es) *
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine

Also Published As

Publication number Publication date
HU907653D0 (en) 1991-06-28
DE69114476T2 (de) 1996-04-18
IL100162A0 (en) 1992-08-18
ZA919352B (en) 1992-09-30
HU208491B (en) 1993-11-29
EP0512109B1 (en) 1995-11-08
NO922961L (no) 1992-09-23
FI923385A (fi) 1992-07-27
DK0512109T3 (da) 1995-12-11
WO1992009299A1 (en) 1992-06-11
EP0512109A1 (en) 1992-11-11
ATE129898T1 (de) 1995-11-15
JPH082795B2 (ja) 1996-01-17
HUT60929A (en) 1992-11-30
DE69114476D1 (de) 1995-12-14
AU8944091A (en) 1992-06-25
JPH05503306A (ja) 1993-06-03
AU651154B2 (en) 1994-07-14
CA2072983A1 (en) 1992-05-28
NZ240762A (en) 1993-05-26
CS230492A3 (en) 1992-12-16
FI923385A0 (fi) 1992-07-27
PT99623A (pt) 1992-12-31
NO922961D0 (no) 1992-07-27
IL100162A (en) 1995-11-27
US5430017A (en) 1995-07-04

Similar Documents

Publication Publication Date Title
MX9102243A (es) Composicion farmaceutica oral que contiene ciclosporina y un proceso para prepararse
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
EP0368388A3 (en) 3-Piperidinyl-1,2-benzisoxazoles
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
PL316942A1 (en) Novel pharmaceutic compositions based on taxoides
HK108994A (en) Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them
PT77309B (de) Isochinolinderivate verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
DE69310052T2 (de) Kardioaktive 17B-(3-Furyl) und 17B-(4-Pyridazinyl)-5beta, 14beta-Androstan Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
SE8006550L (sv) Farmakologisk komposition, samt sett for dess framstellning
PT75492A (de) Sulfonylharnstoffe verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
ES8401946A1 (es) Procedimiento para la preparacion de sulfonilureas.
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
ATE75619T1 (de) Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung.
YU186691A (sh) Postupak za dobijanje oralnog farmaceutskog preparata koji sadrži ciklosporin
TH57759A3 (th) ยาเม็ดที่มีการปลดปล่อยในทันที
SE8704049D0 (sv) Novel pharmacological compounds
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)